In The News Raging At The Pandemic, A VC Raises $800M For A Company That Aims To Transform Biotech Manufacturing The board of the new company, Resilience, includes a who’s who of former industry and government officials. Click here to read the original article in STAT.
Press Release Resilience Launches To Change The Future Of Medicine Through Manufacturing Innovation First-of-its-kind biopharmaceutical manufacturing and technology company broadens access to novel therapies and vaccines while protecting supply... Read on
Press Release Resilience Becomes Biomanufacturing Resource Partner For California Institute For Regenerative Medicine Resilience will aid in the development of CIRM grant applications as a biomanufacturing partner with awardees who are developing novel regenerative... Read on
Press Release Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD San Diego, CA – January 8, 2025 – National Resilience, Inc. (Resilience), a technology-driven biomanufacturing leader dedicated to broadening access... Read on
